Indication · Cardiology
Varicose veins and venous insufficiency
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
41
Cleared or approved since 2000
PMA and De Novo
7
Higher-risk or first-of-kind devices
Breakthrough devices
0
Authorized through June 30, 2026
Recruiting device trials
31
336 device trials in all
Devices
7 devices via PMA. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- VenaSeal Closure System
Medtronic Vascular, Inc. · PMA · Agent, Occluding, Vascular, Permanent · newest 2025 · 6 decisions
6 more devices with a free account
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- Modified Platform Trial Assessing Multiple Umbilical Cord-based CAMPs and SOC v SOC Alone in the Treatment of Hard-to-Heal VLUsPivotal-lookingNot yet recruiting
StimLabsNot on our public-company list
NCT07449988 · 272 participants (planned) · Start Apr 2027 · Primary completion Dec 2029
Device: Corplex P; Theracor · For: Venous Leg Ulcers; Venous Leg Ulcers (VLUs); Venous Leg and 2 more
335 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
Research
- Device studies on varicose veins across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.